Logo image of PRTS

CARPARTS.COM INC (PRTS) Stock Fundamental Analysis

NASDAQ:PRTS - US14427M1071 - Common Stock

0.763 USD
+0.01 (+1.73%)
Last: 8/26/2025, 10:18:35 AM
Fundamental Rating

2

PRTS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 123 industry peers in the Specialty Retail industry. Both the profitability and financial health of PRTS have multiple concerns. PRTS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

PRTS had negative earnings in the past year.
PRTS had a positive operating cash flow in the past year.
In the past 5 years PRTS always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: PRTS reported negative operating cash flow in multiple years.
PRTS Yearly Net Income VS EBIT VS OCF VS FCFPRTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

1.2 Ratios

Looking at the Return On Assets, with a value of -22.83%, PRTS is doing worse than 84.55% of the companies in the same industry.
Looking at the Return On Equity, with a value of -67.89%, PRTS is doing worse than 71.54% of the companies in the same industry.
Industry RankSector Rank
ROA -22.83%
ROE -67.89%
ROIC N/A
ROA(3y)-7.63%
ROA(5y)-5.62%
ROE(3y)-18.62%
ROE(5y)-13.71%
ROIC(3y)N/A
ROIC(5y)N/A
PRTS Yearly ROA, ROE, ROICPRTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

With a Gross Margin value of 33.37%, PRTS perfoms like the industry average, outperforming 41.46% of the companies in the same industry.
In the last couple of years the Gross Margin of PRTS has grown nicely.
PRTS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.37%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.46%
GM growth 5Y2.18%
PRTS Yearly Profit, Operating, Gross MarginsPRTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

More info and screens

3

2. Health

2.1 Basic Checks

PRTS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PRTS has been reduced compared to 1 year ago.
PRTS has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, PRTS has an improved debt to assets ratio.
PRTS Yearly Shares OutstandingPRTS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
PRTS Yearly Total Debt VS Total AssetsPRTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of 0.70, we must say that PRTS is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of PRTS (0.70) is worse than 73.98% of its industry peers.
PRTS has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.11, PRTS is doing good in the industry, outperforming 69.11% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z 0.7
ROIC/WACCN/A
WACC9.75%
PRTS Yearly LT Debt VS Equity VS FCFPRTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

PRTS has a Current Ratio of 1.35. This is a normal value and indicates that PRTS is financially healthy and should not expect problems in meeting its short term obligations.
PRTS's Current ratio of 1.35 is in line compared to the rest of the industry. PRTS outperforms 51.22% of its industry peers.
PRTS has a Quick Ratio of 1.35. This is a bad value and indicates that PRTS is not financially healthy enough and could expect problems in meeting its short term obligations.
PRTS has a Quick ratio of 0.50. This is comparable to the rest of the industry: PRTS outperforms 52.03% of its industry peers.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 0.5
PRTS Yearly Current Assets VS Current LiabilitesPRTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

4

3. Growth

3.1 Past

PRTS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -124.39%.
Looking at the last year, PRTS shows a very negative growth in Revenue. The Revenue has decreased by -12.86% in the last year.
The Revenue has been growing by 15.97% on average over the past years. This is quite good.
EPS 1Y (TTM)-124.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.33%
Revenue 1Y (TTM)-12.86%
Revenue growth 3Y0.37%
Revenue growth 5Y15.97%
Sales Q2Q%5.32%

3.2 Future

Based on estimates for the next years, PRTS will show a very strong growth in Earnings Per Share. The EPS will grow by 28.48% on average per year.
The Revenue is expected to grow by 17.88% on average over the next years. This is quite good.
EPS Next Y-36.97%
EPS Next 2Y12.11%
EPS Next 3Y37.2%
EPS Next 5Y28.48%
Revenue Next Year-2.63%
Revenue Next 2Y-0.04%
Revenue Next 3Y21.78%
Revenue Next 5Y17.88%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
PRTS Yearly Revenue VS EstimatesPRTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
PRTS Yearly EPS VS EstimatesPRTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

PRTS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year PRTS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PRTS Price Earnings VS Forward Price EarningsPRTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PRTS Per share dataPRTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

A more expensive valuation may be justified as PRTS's earnings are expected to grow with 37.20% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.11%
EPS Next 3Y37.2%

More info and screens

0

5. Dividend

5.1 Amount

PRTS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CARPARTS.COM INC

NASDAQ:PRTS (8/26/2025, 10:18:35 AM)

0.763

+0.01 (+1.73%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)08-12 2025-08-12/amc
Earnings (Next)10-27 2025-10-27/amc
Inst Owners37.66%
Inst Owner Change4.32%
Ins Owners9.58%
Ins Owner Change3.17%
Market Cap44.99M
Analysts80
Price Target1.38 (80.87%)
Short Float %1.15%
Short Ratio1.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-69.58%
Min EPS beat(2)-96.08%
Max EPS beat(2)-43.08%
EPS beat(4)0
Avg EPS beat(4)-60.7%
Min EPS beat(4)-96.08%
Max EPS beat(4)-43.08%
EPS beat(8)1
Avg EPS beat(8)-100.66%
EPS beat(12)5
Avg EPS beat(12)52.47%
EPS beat(16)8
Avg EPS beat(16)58.25%
Revenue beat(2)0
Avg Revenue beat(2)-2.96%
Min Revenue beat(2)-4.78%
Max Revenue beat(2)-1.14%
Revenue beat(4)0
Avg Revenue beat(4)-3.82%
Min Revenue beat(4)-9.17%
Max Revenue beat(4)-0.2%
Revenue beat(8)0
Avg Revenue beat(8)-2.99%
Revenue beat(12)1
Avg Revenue beat(12)-2.67%
Revenue beat(16)5
Avg Revenue beat(16)-0.71%
PT rev (1m)-28.95%
PT rev (3m)-28.95%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-23.68%
EPS NY rev (3m)-23.68%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-1.72%
Revenue NY rev (3m)-1.72%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.08
P/FCF N/A
P/OCF 3.69
P/B 0.62
P/tB 0.62
EV/EBITDA N/A
EPS(TTM)-0.92
EYN/A
EPS(NY)-0.52
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)0.21
OCFY27.1%
SpS9.67
BVpS1.23
TBVpS1.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -22.83%
ROE -67.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.37%
FCFM N/A
ROA(3y)-7.63%
ROA(5y)-5.62%
ROE(3y)-18.62%
ROE(5y)-13.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.46%
GM growth 5Y2.18%
F-Score5
Asset Turnover2.63
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 74.59%
Cap/Sales 2.69%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.35
Quick Ratio 0.5
Altman-Z 0.7
F-Score5
WACC9.75%
ROIC/WACCN/A
Cap/Depr(3y)90.52%
Cap/Depr(5y)102.6%
Cap/Sales(3y)2.39%
Cap/Sales(5y)2.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-124.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.33%
EPS Next Y-36.97%
EPS Next 2Y12.11%
EPS Next 3Y37.2%
EPS Next 5Y28.48%
Revenue 1Y (TTM)-12.86%
Revenue growth 3Y0.37%
Revenue growth 5Y15.97%
Sales Q2Q%5.32%
Revenue Next Year-2.63%
Revenue Next 2Y-0.04%
Revenue Next 3Y21.78%
Revenue Next 5Y17.88%
EBIT growth 1Y-190.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year70.63%
EBIT Next 3Y53.37%
EBIT Next 5Y36.7%
FCF growth 1Y-110.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-71.57%
OCF growth 3YN/A
OCF growth 5Y8.48%